STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes

BACKGROUND: Mutations in STAG2 cause complete loss of STAG2 protein in approximately one-third of non–muscle-invasive bladder cancers (NMIBCs). STAG2 protein expression is easily determined via immunohistochemistry (IHC) and published data suggest that loss of STAG2 expression is a good prognostic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Naheema S., Humayun-Zakaria, Nada, Goel, Anshita, Abbotts, Ben, Zeegers, Maurice P., Cheng, K.K., James, Nicholas D., Arnold, Roland, Bryan, Richard T., Ward, Douglas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Urothelial Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051973/
https://www.ncbi.nlm.nih.gov/pubmed/35495284
http://dx.doi.org/10.1016/j.euros.2022.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051973/
https://www.ncbi.nlm.nih.gov/pubmed/35495284
http://dx.doi.org/10.1016/j.euros.2022.02.004

Ejemplares similares